Chris Davis's CVS Position Overview
Chris Davis (via Davis Selected Advisers) currently holds 11.4 M shares of CVS Health Corporation (CVS) worth $859.72 M, representing 4.49% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Chris Davis has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2024, adding 11.02 M shares. Largest reduction occurred in Q1 2014, reducing 21.62 M shares.
Analysis based on 13F filings available since 2013 Q2
Chris Davis's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Chris Davis
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +38.9 M | Add 0.00% | 38.9 M | $57.18 |
| Q3 2013 | -2.45 M | Reduce 6.30% | 36.45 M | $56.75 |
| Q4 2013 | -3.39 M | Reduce 9.30% | 33.06 M | $71.57 |
| Q1 2014 | -21.62 M | Reduce 65.41% | 11.44 M | $74.86 |
| Q2 2014 | -2.42 M | Reduce 21.19% | 9.01 M | $75.37 |
| Q3 2014 | -6.86 M | Reduce 76.10% | 2.15 M | $79.60 |
| Q4 2014 | -2.15 M | Sold Out | 2.15 M | $0.00 |
| Q4 2018 | +1.13 M | New Buy | 1.13 M | $65.51 |
| Q1 2019 | -5,820 | Reduce 0.52% | 1.12 M | $53.93 |
| Q2 2019 | -22,557 | Reduce 2.01% | 1.1 M | $54.49 |
| Q3 2019 | -36,147 | Reduce 3.28% | 1.07 M | $63.07 |
| Q4 2019 | -253,227 | Reduce 23.77% | 812,308 | $74.29 |
| Q1 2020 | -7,689 | Reduce 0.95% | 804,619 | $59.33 |
| Q2 2020 | +7,998 | Add 0.99% | 812,617 | $64.97 |
| Q3 2020 | -14,422 | Reduce 1.77% | 798,195 | $58.40 |
| Q4 2020 | -6,796 | Reduce 0.85% | 791,399 | $68.30 |
| Q1 2021 | -10,120 | Reduce 1.28% | 781,279 | $75.23 |
| Q2 2021 | -853 | Reduce 0.11% | 780,426 | $83.44 |
| Q3 2021 | -1,226 | Reduce 0.16% | 779,200 | $84.86 |
| Q4 2021 | -565,467 | Reduce 72.57% | 213,733 | $103.16 |
| Q1 2022 | -5,309 | Reduce 2.48% | 208,424 | $101.21 |
| Q2 2022 | -152 | Reduce 0.07% | 208,272 | $92.66 |
| Q3 2022 | -904 | Reduce 0.43% | 207,368 | $95.37 |
| Q4 2022 | +722 | Add 0.35% | 208,090 | $93.19 |
| Q1 2023 | -144 | Reduce 0.07% | 207,946 | $74.31 |
| Q2 2023 | -137 | Reduce 0.07% | 207,809 | $69.13 |
| Q3 2023 | -3,177 | Reduce 1.53% | 204,632 | $69.82 |
| Q4 2023 | +1,782 | Add 0.87% | 206,414 | $78.96 |
| Q1 2024 | -33,671 | Reduce 16.31% | 172,743 | $79.76 |
| Q2 2024 | +192,039 | Add 111.17% | 364,782 | $59.06 |
| Q3 2024 | +2,730 | Add 0.75% | 367,512 | $62.88 |
| Q4 2024 | +11.02 M | Add 2998.12% | 11.39 M | $44.89 |
| Q1 2025 | +163,107 | Add 1.43% | 11.55 M | $67.75 |
| Q2 2025 | +37,733 | Add 0.33% | 11.59 M | $68.98 |
| Q3 2025 | -183,149 | Reduce 1.58% | 11.4 M | $75.39 |
Chris Davis's CVS Health Corporation Investment FAQs
Chris Davis first purchased CVS Health Corporation (CVS) in Q2 2013, acquiring 38,896,601 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chris Davis has held CVS Health Corporation (CVS) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chris Davis's largest addition to CVS Health Corporation (CVS) was in Q2 2013, adding 38,896,601 shares worth $2.22 B. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Chris Davis's firm, Davis Selected Advisers, owns 11,403,641 shares of CVS Health Corporation (CVS), valued at approximately $859.72 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, CVS Health Corporation (CVS) represents approximately 4.49% of Chris Davis's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chris Davis's peak holding in CVS Health Corporation (CVS) was 38,896,601 shares, as reported at the end of Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.